Skip to Content
 

VICC toll-free number 1-877-936-8422

Endocrine Cancers

Clinical Trials for Endocrine Cancers

3 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCTHO1722

05/26/2017

Phase I Study of TRC102 in Combination with Cisplatin and Pemetrexed in Patients with Advanced Solid Tumors, with Expansion Cohort in Mesothelioma / Phase II Study of TRC102 with Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin

Treatment

VICCPED16157

04/24/2017

NMTT-Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Treatment

VICCMD15110

04/05/2016

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors